Abstract
Corneal endothelial disease is a major cause of vision loss worldwide, with transplantation often being the only treatment. Surgical procedures like cataract surgery involve intracameral irrigation, which can cause acute ocular hypertension and damage the non-regenerative corneal endothelium. This study investigates the protective effects of N-(2)-L-alanyl-L-glutamine (Ala-Gln), a stable dipeptide, as an additive to irrigation fluids. Using a mouse model of acute ocular hypertension, researchers found that Ala-Gln significantly preserves endothelial cell density, morphology, and pump function by protecting mitochondrial integrity and the cellular cytoskeleton.
Introduction
The corneal endothelium is a critical single layer of cells responsible for maintaining corneal transparency through its "pump-leak" mechanism. Unlike many other tissues, human corneal endothelial cells (CECs) have extremely limited regenerative capacity. Loss of these cells during intraocular surgery due to mechanical stress or pressure spikes can lead to permanent corneal edema and blindness. While glutamine is known for its cytoprotective properties, its instability makes it unsuitable for clinical use. Ala-Gln, a heat-stable dipeptide, offers a promising alternative for ophthalmic irrigation solutions.
Methods
Researchers utilized an in vivo mouse model (ICR mice) to simulate surgical stress. Acute ocular hypertension was induced by increasing intraocular pressure to 44 ± 3.5 mmHg (approximately four times the normal level) for 60 minutes via intracameral irrigation.
Two groups were compared:
- Control Group: Irrigated with standard Ringer’s lactate.
- Experimental Group: Irrigated with Ringer’s lactate supplemented with 5mM Ala-Gln.
Evaluation techniques included In Vivo Confocal Microscopy (IVCM) for cell density, Optical Coherence Tomography (OCT) for corneal thickness, and electron microscopy (SEM/TEM) for ultrastructural analysis of mitochondria and the cytoskeleton.
Results and Discussion
Preservation of Cell Density and Morphology
IVCM results demonstrated that the addition of Ala-Gln significantly protected the structure and density of the corneal endothelium. Immediately following irrigation (Day 0), the Ala-Gln group maintained a cell density of 2774.4 ± 276.7 cells/mm², whereas the Ringer’s-only control group dropped to 1807 ± 463.3 cells/mm².
Mitochondrial and Cytoskeletal Protection
The study identified mitochondrial protection as a primary mechanism of Ala-Gln. In control mice, high pressure caused mitochondria to become distended with degraded internal structures (cristae). Ala-Gln treatment maintained mitochondrial morphology and activity, ensuring the energy supply required for the Na-K-ATPase pump. Furthermore, Ala-Gln prevented the collapse of the F-actin cytoskeleton, which typically leads to cell sloughing under high-pressure conditions.
Recovery from Edema
While both groups experienced immediate corneal swelling after irrigation, the Ala-Gln group showed a significantly faster recovery. By Day 10, corneal thickness in the experimental group returned to normal levels, while the control group continued to exhibit significant edema.
Conclusion
Intracameral irrigation with Ala-Gln effectively maintains corneal endothelial pump and barrier functions during acute ocular hypertension. By protecting mitochondrial health and preventing cytoskeletal rearrangement, Ala-Gln serves as a potent cytoprotective agent. These findings suggest that Ala-Gln could be a valuable addition to surgical irrigation fluids to improve outcomes in ophthalmic surgery, though further validation in human models is required.
Summary updated